Clinical Trial Update: Second Line Oxaliplatin Based Chemotherapy Alone Versus Oxaliplatin Based PIPAC and Chemotherapy in Colorectal Peritoneal Carcinomatosis : A Phase II Randomize Mutli-centric Study [Phase 2]

View source ↗

Summary

A phase II randomized multicenter trial comparing second-line oxaliplatin-based chemotherapy alone versus oxaliplatin-based chemotherapy with PIPAC in colorecta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Peritoneal Carcinomatosis

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• PIPAC (Pressurized intraperitoneal aerosol chemotherapy)

Snippet

Sponsor: Sleiman Marwan-Julien | Conditions: Peritoneal Carcinomatosis | Phase 2 | Status: UNKNOWN